The Board of Directors has appointed Christoph Heinzen as the new Chief Executive Officer at Nexilis AG. Christoph Heinzen has a strong track record in various positions in the pharmaceutical, BioTech and MedTech Industry with more than 20 years of experience, e.g. as Chief Operations and Technology Officer at LifeWatch AG, a company dedicated to ECG monitoring services.
Christoph holds an Ph.D. in process engineering (ETHZ) and MBA (BWI NDS ETHZ).
Christoph holds an Ph.D. in process engineering (ETHZ) and MBA (BWI NDS ETHZ).
RSS Feed
